NFKB1 and central nervous system cancer: Research by Zhao et al. indicated that WWP1 inhibits NF-κB activation, a pathway linked to glioma formation, and is downregulated in glioma tissues, possibly targeted by miR-30a-5p (Wang et al., 2015; Park et al., 2020) (Figure 5A).